nusep paid asx a fee of $8,250.
since the issue of them, a significant part of the funds has been used by nusep for nusep's business purposes disclosed in the prospectus.
the demerger process involved the issue of 4,934,591 shares in nusep to all holders of shares in life therapeutics --- one nusep share for every 20 shares held in life therapeutics.